A21D (p.Ala21Asp) variant of GATA6 (Transcription factor GATA-6)

A21D (p.Ala21Asp) in GATA6 (Transcription factor GATA-6) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.43 / 1. The record also includes population frequency data and structural context.

A21D (p.Ala21Asp) variant details